Capricor Therapeutics CAPR
NASDAQ CAPR
$8.95 +0.01 (+0.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Asset Writedowns and Impairment (2013)

Updated

Capricor Therapeutics (CAPR) posted Asset Writedowns and Impairment of $1.5 million for FY2016.

Analysis

Capricor Therapeutics (CAPR) Asset Writedowns and Impairment (2013) Analysis & Trends

  • Annual Asset Writedowns and Impairment shows a three-year compound annual growth rate of -7.9% (FY2013 to FY2016).
  • The FY2016 figure stands as the highest annual Asset Writedowns and Impairment since FY2013.
  • Business Quant data shows CAPR's Asset Writedowns and Impairment at $1.92 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Capricor Therapeutics 520.08 Mn 520.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 1.92 Mn
API Access

Capricor Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=CAPR&period=max&api_key=YOUR_API_KEY